MedPath

Usability and Effectiveness of ReHub in Patients After Total Hip Arthroplasty

Not Applicable
Terminated
Conditions
Hip Osteoarthritis
Interventions
Other: Conventional Home-based Rehabilitation Plan
Device: ReHub Home-based Rehabilitation Plan
Registration Number
NCT04176315
Lead Sponsor
Bio-Sensing Solutions S.L. (DyCare)
Brief Summary

This is a randomized, non-blinded, parallel assignment, clinical trial for the evaluation of usability and effectiveness of ReHub, a telerehabilitation system made up of a cloud platform and an exercise kit with smart sensors, for performing rehabilitation exercises after a primary Total Hip Arthroplasty (THA).

Patients admitted to Presidio San Camillo after a THA surgery are randomly allocated to the control arm or the experimental arm with a 1:1 ratio. Participants in both arms receive inpatient care and rehabilitation for 2 weeks at San Camillo. At discharge, they are prescribed with the same daily plan of 5 exercises for autonomous home-based rehabilitation. The experimental arm participants use ReHub to do their exercises instead of working independently and physiotherapists monitor their performance and adherence remotely.

Outcomes assessment is performed at San Camillo admission (baseline), at San Camillo discharge (2 weeks from baseline) and 3 weeks after San Camillo discharge (5 weeks from baseline).

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
38
Inclusion Criteria
  • Ability to understand and accept the clinical study procedure and to sign an informed consent form
  • Good familiarity with the Italian language
  • Good predisposition to the use of technology or availability of a caregiver providing technological support to the patient
  • Availability to move to the Rehabilitation Center for control visits
Exclusion Criteria
  • Age <60 or >80 years
  • Admission after THA revision surgery
  • Contralateral hip osteoarthritis severely limiting patient mobility and ability to comply with a rehabilitation program
  • Aphasia, dementia, or psychiatric comorbidity interfering with communication or adherence to the rehabilitation process
  • Respiratory, cardiac, metabolic, or other condition limiting patient mobility and ability to comply with a rehabilitation program
  • Major medical complications occurring after surgery that prevented the discharge of the patient within 10 days after the surgery
  • Body mass index >35kg/m2

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Conventional Rehabilitation GroupConventional Home-based Rehabilitation PlanParticipants follow the usual exercise plan designed at Presidio San Camillo for Total Hip Arthroplasty autonomously
ReHub GroupReHub Home-based Rehabilitation PlanParticipants follow the usual exercise plan designed at Presidio San Camillo for Total Hip Arthroplasty but use the telerehabilitation platform ReHub to do the exercises at home and to have their progress monitored.
Primary Outcome Measures
NameTimeMethod
Change in the Timed Up-and-Go test score (s)Baseline, 2 weeks and 5 weeks from baseline

The TUG test outcome is the time that a person takes to rise from a chair, walk three meters, turn around, walk back to the chair, and sit down as the score.

Secondary Outcome Measures
NameTimeMethod
Change in Hip Extension Range of Motion (º)Baseline, 2 weeks and 5 weeks from baseline

Range of motion of the replaced hip for extension, without the aid of the outcomes assessor, is measured with a conventional goniometer.

Change in Hip Flexion Range of Motion (º)Baseline, 2 weeks and 5 weeks from baseline

Range of motion of the replaced hip for flexion, without the aid of the outcomes assessor, is measured with a conventional goniometer.

Change in Hip Abduction Range of Motion (º)Baseline, 2 weeks and 5 weeks from baseline

Range of motion of the replaced hip for abduction, without the aid of the outcomes assessor, is measured with a conventional goniometer.

Change in Abduction Strength (kg)Baseline, 2 weeks and 5 weeks from baseline

Strength of the intervened leg while performing an abduction movement is measured with a dynamometer.

Change in Quadriceps Strength (kg)Baseline, 2 weeks and 5 weeks from baseline

Strength of the quadriceps in the intervened leg is measured with a dynamometer.

Satisfaction with ReHub: System Usability Scale5 weeks from baseline

Measured with the score from the System Usability Scale questionnaire, which can range from 0 (worst result) to 100 (best result). Only for participants in the experimental arm.

Change in Extension Strength (kg)Baseline, 2 weeks and 5 weeks from baseline

Strength of the intervened leg while performing an extension movement is measured with a dynamometer.

Global Rating Of Change5 weeks from baseline

The participant will report their perception of change from the start to the end of the study with a number from 1 (substantial worsening) to 6 (total recovery).

Change in Self-Reported Pain Level in Movement: Numerical Rating ScaleBaseline, 2 weeks and 5 weeks from baseline

The pain level of the intervened hip in movement is reported by the participant with a Numerical Rating Scale from 0 to 10, with 0 being the absence of pain and 100 being the worst possible pain.

Change in Hip disability and Osteoarthritis Outcome Score (HOOS)Baseline, 2 weeks and 5 weeks from baseline

Scores for the HOOS questionnaire range from 0% to 100%, with 0 being the worst possible score and 100 the best possible score.

Change in Functional Independence Measure (FIM) scoreBaseline, 2 weeks and 5 weeks from baseline

Scores for the FIM questionnaire range from 18 to 126, with 13 being the worst possible score and 100 the best possible score. Individual items (18) are scored from 1 (worst) to 7 (best).

Change in Self-Reported Pain Level at Rest: Numerical Rating ScaleBaseline, 2 weeks and 5 weeks from baseline

The pain level of the intervened hip at rest is reported by the participant with a Numerical Rating Scale from 0 to 10, with 0 being the absence of pain and 100 being the worst possible pain.

Trial Locations

Locations (1)

Presidio Sanitario San Camillo

🇮🇹

Turin, Piemonte, Italy

© Copyright 2025. All Rights Reserved by MedPath